| Tofogliflozin treatment group | Conventional treatment group | Treatment effect (tofogliflozin–conventional treatment) (mean change [95% CI]) |
---|---|---|---|
Right baPWV (cm/s) (mean change; SE) | Â | ||
 Week 52 (n = 138) | 1.3 (39.9) | 77.0 (38.8) | − 75.5 (− 171.1, 19.7), p = 0.12 |
 Week 104 (n = 130) | − 67.9 (32.5) | 34.7 (31.5) | − 102.7 (− 182.1, − 23.2), p = 0.012 |
Left baPWV (cm/s) (mean change; SE) | Â | ||
 Week 52 (n = 138) | − 7.1 (40.1) | 76.2 (39.1) | − 83.3 (− 179.3, 12.8), p = 0.09 |
 Week 104 (n = 130) | − 33.7 (32.2) | 67.6 (31.4) | − 101.3 (− 180.3, − 22.3), p = 0.012 |
Mean baPWV (cm/s) (mean change; SE) | Â | ||
 Week 52 (n = 138) | − 4.2 (39.2) | 76.9 (38.1) | − 81.2 (− 174.9, 12.6), p = 0.09 |
 Week 104 (n = 130) | − 51.9 (31.4) | 51.2 (30.5) | − 103.1 (− 180.1, − 26.2), p = 0.009 |